USD 12.32 billion
Report ID:
SQMIG35A2584 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|Tables:
65
|Figures:
75
Global Transcatheter Devices Market size was valued at USD 12.32 billion in 2022 and is poised to grow from USD 13.99 billion in 2023 to USD 38.66 billion by 2031, growing at a CAGR of 13.55% in the forecast period (2024- 2031).
The global transcatheter devices market offers intriguing insights into the healthcare sector's evolving landscape. With a growing emphasis on minimally invasive procedures, transcatheter devices have gained significant traction due to their potential to revolutionize treatment approaches. These devices cater to a wide range of medical conditions, including cardiovascular diseases and structural heart defects, allowing for precise interventions without the need for open surgeries.
The market's growth is driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in medical technology. As medical professionals and patients alike seek treatments that offer shorter recovery times and reduced complications, transcatheter devices have emerged as a compelling solution. However, regulatory challenges, reimbursement issues, and the requirement for specialized training can present hurdles to market expansion. Nevertheless, ongoing research and innovation in device design, coupled with collaborative efforts between healthcare providers and manufacturers, are expected to shape the future of the global transcatheter devices market.
US Transcatheter Devices Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 12.32 billion
Largest Segment
Cardiovascular
Fastest Growth
Oncology
Growth Rate
13.55% CAGR
To get more reports on the above market click here to Buy The Report
The global Transcatheter Devices Market is segmented into three i.e. Application, Product, and Region. Based on Application the market is segmented as, Cardiovascular, Oncology, Neurology, Urology, and Others. Based on Product, the market is bifurcated as, Transcatheter Embolization and Occlusion Devices, Transcatheter Replacement Devices, Transcatheter Repair Devices. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Transcatheter Devices Market Analysis by Product
Transcatheter Replacement Devices are emerging as the dominating segment. This dominance can be attributed to the significant strides made in transcatheter heart valve replacements, particularly in treating valvular diseases like aortic stenosis. Transcatheter heart valve replacements have revolutionized the field by offering minimally invasive alternatives to traditional open-heart surgery. This approach has gained popularity due to reduced procedural risks, shorter hospital stays, and quicker patient recovery times.
However, Transcatheter Embolization and Occlusion Devices are emerging as one of the fastest-growing segments. This growth can be attributed to their versatility and application across various medical fields. Transcatheter embolization and occlusion devices offer minimally invasive solutions for managing conditions such as aneurysms, vascular malformations, and tumors by blocking blood flow or redirecting it away from affected areas. As medical professionals increasingly recognize the benefits of less invasive procedures for patients, the demand for these devices has surged. Their ability to offer targeted treatment options, reduced hospital stays, and quicker recovery times contributes to their rapid market expansion.
Transcatheter Devices Market Analysis by Application
The cardiovascular segment stands out as the dominating and largest application in the global transcatheter devices market. This prominence can be attributed to the high prevalence of cardiovascular diseases worldwide, coupled with the growing preference for minimally invasive procedures. Transcatheter devices offer a revolutionary approach to treating various cardiac conditions, including coronary artery disease, valvular heart diseases, and congenital heart defects, without the need for traditional open surgeries.
However, oncology is emerging as the fastest-growing segment. This growth can be attributed to the increasing demand for minimally invasive treatment options for various types of cancers, including liver, lung, kidney, and bone metastases. The rising incidence of cancer globally, coupled with the potential for reduced side effects and improved patient outcomes, is driving the adoption of transcatheter devices in oncology. Additionally, advancements in imaging technologies and interventional radiology techniques are enhancing the accuracy and effectiveness of these treatments, further propelling the growth of the oncology application within the transcatheter devices market.
To get detailed analysis on other segments, Request For Free Sample Report
North America emerges as the dominating region in the global transcatheter devices market. This prominence is rooted in the region's advanced healthcare infrastructure, substantial investments in medical research and innovation, and high prevalence of chronic diseases such as cardiovascular conditions. The availability of skilled healthcare professionals, favorable reimbursement policies, and a proactive approach towards adopting novel medical technologies contribute to North America's leadership position.
However, Asia Pacific emerges as the fastest-growing market in the global transcatheter devices sector. This growth is attributed to several factors, including a rising geriatric population, increasing prevalence of chronic diseases, and improving healthcare infrastructure in the region. As healthcare awareness and access expand, there is a growing demand for advanced medical interventions, such as transcatheter procedures, which offer reduced recovery times and fewer complications.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Transcatheter Devices Market Drivers
Advancements in Minimally Invasive Techniques
Transcatheter Devices Market Restraints
Regulatory Challenges and Stringent Approval Processes
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape of the global transcatheter devices market is marked by a dynamic interplay of established medical device manufacturers and innovative startups. Companies within this landscape strive to leverage cutting-edge technology to develop minimally invasive solutions that address various medical conditions across applications such as cardiovascular, oncology, neurology, and urology. The pursuit of enhanced patient outcomes reduced procedural complexities, and shorter recovery times has fueled intense competition.
Collaborations, partnerships, and strategic alliances are commonplace as market players seek to capitalize on each other's strengths and expand their global reach. The market's evolution is driven by continuous research and development efforts, with a focus on refining device design, optimizing procedural techniques, and adhering to regulatory requirements. As healthcare providers and patients increasingly favor minimally invasive interventions, the competitive landscape of the transcatheter devices market is characterized by a persistent drive for innovation and improved patient care.
Transcatheter Devices Market Top Player’s Company Profiles
Transcatheter Devices Market Recent Developments
In October 2023, Laguna Tech USA accomplished effective clinical results in patients with aortic regurgitation using its Zeta balloon-expandable aortic valve system and Alpha self-expanding aortic valve system. As per a statement delivered on October 25, the US-based organization finished its first-in-human clinical case utilizing the Zeta system. Laguna likewise detailed the effective treatment of extra patients with its Alpha self-expanding aortic valve system in a practical study. Moreover, Laguna expressed that the device brought about the complete goal of aortic regurgitation in two patients, with supported results seen during a 30-day follow-up period.
In November 2023, Meril Life Sciences consented to a partnership agreement with Japan Lifeline to extend its worldwide presence. This strategic alliance grants Japan Lifeline elite rights to advance Meril's Transcatheter Heart Valve, Myval Octacor, when it gets PMD approval in Japan.
In November 2023, Anteris Technologies Ltd CEO Wayne Paterson imparted to Proactive about finishing enlistment for the company's early feasibility study (EFS) for DurAVR™ THV. This creative device, the world's only balloon-expandable, single-piece transcatheter aortic valve, is going through testing to treat 15 patients with indicative, extreme native aortic stenosis. The review is vital for acquiring freedom from the US Food and Drug Administration (FDA).
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to global transcatheter devices market analysis, the market has experienced significant growth over the past years, driven by advancements in medical technology and increasing demand for minimally invasive procedures. Transcatheter devices offer a less invasive alternative to traditional surgical methods, often leading to reduced patient discomfort, shorter hospital stays, and quicker recovery times. This market encompasses a wide range of applications, including transcatheter heart valves, transcatheter embolization devices, and transcatheter closure devices.
Factors such as a growing aging population, rising prevalence of cardiovascular diseases, and increasing awareness of these innovative procedures among patients and healthcare providers are propelling market expansion. However, challenges such as stringent regulatory requirements, high upfront costs, and the need for specialized training could potentially hinder the market's growth trajectory.
As technological innovation continues to evolve and healthcare systems adapt, the transcatheter devices market is poised to maintain its upward trajectory, providing patients with improved treatment options and healthcare providers with efficient solutions.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 12.32 billion |
Market size value in 2031 | USD 38.66 billion |
Growth Rate | 13.55% |
Base year | 2023 |
Forecast period | 2024- 2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Transcatheter Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Transcatheter Devices Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Transcatheter Devices Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Transcatheter Devices Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2584
sales@skyquestt.com
USA +1 351-333-4748